Rothschild & Co SCA (Rothschild & Co) is a French-based global financial services group organized as a partnership limited by shares and headquartered in Paris. The firm provides independent financial advisory services on mergers and acquisitions, strategic reviews, capital structure and financing, and restructuring. It also offers wealth and asset management for private and institutional clients, and invests through its merchant banking activities in private equity and credit strategies.
With offices across Europe, the Americas, the Middle East, and Asia-Pacific, Rothschild & Co advises corporations, private equity firms, family-owned businesses, and governments in a broad range of sectors, including chemicals and wider industrials. The group traces its heritage to the 19th-century Rothschild banking houses and undertakes cross-border advisory assignments for clients worldwide.
Also known as NM Rothschild.
None yet. When a new project in the record names Rothschild & Co as owner, partner or investor, it shows here.
Net profit USD 1m; sold ammonia distribution and monetized Methanex; OCI Nitrogen impaired and facing margin pressure; held‑for‑sale net cash USD 1.05bn; NNS offer and Orascom deal progressing.
Board (excluding Nassef and Nadia Sawiris) backs NNS cash offer and court-appointed directors agree to convene an EGM to approve the Orascom transaction, conditional on NNS declaring and settling the offer.
Adds full NPK fertilizer technologies, fluorine and oleochemistry capabilities; integrates ~460 staff, pilot plants and a €270m backlog; transaction paid at €148.2m.
Placed at €89.35 each (7% of capital), reducing stake to ~24%; private accelerated bookbuild to qualified/institutional investors; proceeds to strengthen finances and fund growth.
Will act as exclusive offtaker of Gabon’s Profit Oil; crude sourced from a diversified pool of producing assets; syndication of exposure is underway.
CABB shifts focus to Pharma and Life Science, selling Jayhawk for $150M. Anupam Rasayan aims to expand its US presence and performance materials business.
CABB shifts focus to Pharma and Life Science, selling Jayhawk for $150M. Anupam Rasayan aims to expand in the US and enhance its performance materials business. Transaction closes in January.
The merger creates a scalable infrastructure platform with three strategic pillars, enhancing growth and diversification, led by Nassef Sawiris as Non-Executive Chair.
